Fig. 1.

Initial treatment of metastatic melanoma. a ¹⁸FDG-PET-CT scan of the patient when the metastatic disease was diagnosed. b ¹⁸FDG-positive lung lesion at the initial diagnosis of metastatic BRAF mutated melanoma. c Initial treatment response to BRAF and MEK inhibitors and to pembrolizumab over time